K. T. Chong

Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor

Susan M. Poppe, Dea Slade, K. T. Chong et al. · Antimicrobial Agents and Chemotherapy · 1997 · 121 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria

K. T. Chong · Infection and Immunity · 1987 · 58 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro

K. T. Chong, P J Pagano, Roger R. Hinshaw · Antimicrobial Agents and Chemotherapy · 1994 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates

K. T. Chong, P J Pagano · Antimicrobial Agents and Chemotherapy · 1997 · 42 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Interferon as a Defence Mechanism in Mouse Cytomegalovirus Infection

K. T. Chong, Ion Gresser, Cedric Mims · Journal of General Virology · 1983 · 40 citations

Life Sciences, Immunology, Infectious Diseases +16